Literature DB >> 26419218

A familial pericentric inversion of chromosome 11 associated with a microdeletion of 163 kb and microduplication of 288 kb at 11p13 and 11q22.3 without aniridia or eye anomalies.

Lara Balay1, Ellen Totten2, Luna Okada3, Sidney Zell4, Benjamin Ticho4, Jeannette Israel4, Jillene Kogan2,5.   

Abstract

Interstitial deletions of 11p13 involving MPPED2, DCDC5, DCDC1, DNAJC24, IMMP1L, and ELP4 are previously reported to have downstream transcriptional effects on the expression of PAX6, due to a downstream regulatory region (DRR). Currently, no clear genotype-phenotype correlations have been established allowing for conclusive information regarding the exact location of the PAX6 DRR, though its location has been approximated in mouse models to be within the Elp4 gene. Of the clinical reports currently published examining patients with intact PAX6 genes but harboring deletions identified in genes downstream of PAX6, 100% indicate phenotypes which include aniridia, whereas approximately half report additional eye deformities, autism, or intellectual disability. In this clinical report, we present a 12-year-old male patient, his brother, and mother with pericentric inversions of chromosome 11 associated with submicroscopic interstitial deletions of 11p13 and duplications of 11q22.3. The inversions were identified by standard cytogenetic analysis; microarray and FISH detected the chromosomal imbalance. The patient's phenotype includes intellectual disability, speech abnormalities, and autistic behaviors, but interestingly neither the patient, his brother, nor mother have aniridia or other eye anomalies. To the best of our knowledge, these findings in three family members represent the only reported cases with 11p13 deletions downstream of PAX6 not demonstrating phenotypic characteristics of aniridia or abnormal eye development. Although none of the deleted genes are obvious candidates for the patient's phenotype, the absence of aniridia in the presence of this deletion in all three family members further delineates the location of the DRR for PAX6.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  11p13 deletion; 11q22.3 duplication; PAX6; PAX6 downstream regulatory region; aniridia

Mesh:

Substances:

Year:  2015        PMID: 26419218     DOI: 10.1002/ajmg.a.37388

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  The value of genomic variant ClinVar submissions from clinical providers: Beyond the addition of novel variants.

Authors:  Karen E Wain; Emily Palen; Juliann M Savatt; Devin Shuman; Brenda Finucane; Andrea Seeley; Thomas D Challman; Scott M Myers; Christa Lese Martin
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

Review 2.  Aniridia due to a novel microdeletion affecting PAX6 regulatory enhancers: case report and review of the literature.

Authors:  Andreas Syrimis; Nayia Nicolaou; Angelos Alexandrou; Ioannis Papaevripidou; Michael Nicolaou; Eleni Loukianou; Violetta Christophidou-Anastasiadou; Stavros Malas; Carolina Sismani; George A Tanteles
Journal:  J Genet       Date:  2018-06       Impact factor: 1.166

Review 3.  The genetics of aniridia - simple things become complicated.

Authors:  Anna Wawrocka; Maciej R Krawczynski
Journal:  J Appl Genet       Date:  2018-02-19       Impact factor: 3.240

4.  Submicroscopic 11p13 deletion including the elongator acetyltransferase complex subunit 4 gene in a girl with language failure, intellectual disability and congenital malformations: A case report.

Authors:  Jaime Toral-Lopez; Luz María González Huerta; Olga Messina-Baas; Sergio A Cuevas-Covarrubias
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

5.  A sporadic case of congenital aniridia caused by pericentric inversion inv(11)(p13q14) associated with a 977 kb deletion in the 11p13 region.

Authors:  Tatyana A Vasilyeva; Andrey V Marakhonov; Marina E Minzhenkova; Zhanna G Markova; Nika V Petrova; Natella V Sukhanova; Philipp A Koshkin; Denis V Pyankov; Ilya V Kanivets; Sergey A Korostelev; Irina A Krynskaya; Nadezhda V Shilova; Sergey I Kutsev; Vitaly V Kadyshev; Rena A Zinchenko
Journal:  BMC Med Genomics       Date:  2020-09-18       Impact factor: 3.063

6.  MR-PheWAS for the causal effects of serum magnesium on multiple disease outcomes in Caucasian descent.

Authors:  Longman Li; Wenjun Yang; Lulu Huang; Xiuming Feng; Hong Cheng; Xiaoting Ge; Gaohui Zan; Yanli Tan; Lili Xiao; Chaoqun Liu; Xing Chen; Zengnan Mo; Xiaobo Yang
Journal:  iScience       Date:  2021-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.